Data Security Policy

Clinical Validity and Disclaimers

Personalized Prescribing Inc. (PPI) provides medication recommendations based on gene-drug interactions validated by international pharmacogenetics consortia, such as CPIC and DPWG. Where interactions lack full validation, information is shared with clear disclaimers exclusively to healthcare providers.

Use of Genetic Information

Genetic data guides personalized medication recommendations exclusively. The company does not conduct whole genome sequencing or assess disease risk. While current results show no disease risk indicators, emerging research may eventually associate certain variants with future clinical findings.

Data Protection Measures

PPI employs encrypted, firewalled databases and secure systems for data protection. Although no system guarantees absolute security, the company implements reasonable safeguards against unauthorized access.

Certification and Accreditation

Privacy and Confidentiality

• Data anonymization uses unique Sample IDs separating identifiers from DNA samples

• Genetic information stored securely for 25 years (CLIA/CAP standards)

• DNA samples retained 90 days or until next proficiency testing

• Identifiable reports shared only with treating healthcare providers per consent

• Authorized personnel access limited to operational necessity

Research and Aggregate Use

De-identified data supports internal research, quality improvement, and scientific publications, focusing on population-level medication response patterns.

Record Retention

Upon organizational closure, physical records undergo secure shredding. Servers remain active for one year post-closure to permit necessary data retrieval, then permanent deletion occurs per data protection standards.

Security Breach

In case of accidental or unlawful data destruction, loss, alteration, or unauthorized disclosure, PPI assesses risks to individual rights and freedoms, reporting breaches to appropriate parties per applicable data protection laws.

Your Rights